Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth.

Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth. Cancer Immunol Res. 2021 04; 9(4):415-429.

View in: PubMed

subject areas

Adoptive Transfer
Animals
Antineoplastic Agents
Arginase
CD8-Positive T-Lymphocytes
Cell Line, Tumor
Disease Models, Animal
Female
Humans
Immunotherapy
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Neoplasm Transplantation
Programmed Cell Death 1 Receptor
Receptors, OX40

authors with profiles

Alexander Muir